It has been reported that 13 genes were hypermethylated in hormone receptor (HR)+, luminal A, or p53 wild-type breast cancers, while 9 genes were hypermethylated in HR−, basal-like, or p53 mutant tumors, indicating differences in DNA methylation patterns among breast cancer subtypes [32]. Here, TP53 is linked to breast cancer.